Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Breast Cancer|June 28, 2006
Concordance between central and local laboratory HER2 testing from a community-based clinical studyJosina C Reddy, James D Reimann, Steven M Anderson, et al.
The Oncologist|March 11, 2022
Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with CancerRuoding Tan, Cindy Yun, Arpamas Seetasith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remissionStanley B Kaye, Louis Fehrenbacher, Robert Holloway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
Pharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: the role of alpha-1-acid glycoprotein bindingRichard A Graham, Bert L Lum, Sravanthi Cheeti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumorsPatricia M LoRusso, Charles M Rudin, Josina C Reddy, et al.
The New England Journal of Medicine|September 4, 2009
Inhibition of the hedgehog pathway in advanced basal-cell carcinomaDaniel D Von Hoff, Patricia M LoRusso, Charles M Rudin, et al.
The New England Journal of Medicine|June 8, 2012
Efficacy and safety of vismodegib in advanced basal-cell carcinomaAleksandar Sekulic, Michael R Migden, Anthony E Oro, et al.
Pageof 1